Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-26

Clinical Trial Update: Ibuprofen to Decrease Opioid Use and Post-operative Pain Following Unilateral Inguinal Herniorrhaphy [Phase 3]

View source ↗

Summary

Phase 3 trial investigating ibuprofen to reduce opioid use and post-operative pain after unilateral inguinal herniorrhaphy; study terminated with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Mike O'Callaghan Military Hospital | Conditions: Pain, Hernia | Phase 3 | Status: TERMINATED | Results posted: 2024-03-26